mRNA: Decoding the Future Beyond Vaccines
Self-Amplifying RNA: Redefining RNA-Based Therapeutics The global RNA therapeutics market is slated to reach $940-$950 million by 2035. Out of several promising advancements driving this growth, self-amplifying RNA therapeutics are currently leading the pack. saRNA vaccines offer protective immunity at doses that are 1,000,000-fold lower than their mRNA counterparts, with optimized platforms in preclinical models. […]
Identifying Growth Pathways to Navigate the Competitive Biosimilar Landscape
Client Background: The client is a leading global biopharmaceutical player seeking a structured assessment of competitor portfolios, manufacturing capabilities, pricing approaches, and emerging opportunities to guide long-term business strategies. Challenges: Engagement Objective: The engagement aimed to deliver an in-depth analysis of the biosimilar competitive landscape, identify competitive advantage, emerging opportunities, and strategic growth pathways to […]
Winning in the Margins: Commercial Strategy for New Entrants in the Adalimumab Autoinjector Market
Overview The adalimumab autoinjector market is becoming increasingly competitive, with multiple biosimilar manufacturers challenging established brands through aggressive pricing, product innovation, and evolving market access strategies. With 10 biosimilar competitors examined and discount levels reaching up to 85% versus Humira in the research, the commercial challenge extends beyond affordability. New entrants must differentiate through formulation, […]
Threat and Opportunity Assessment for Pharmaceutical Products
A pharmaceutical product is any drug product that is approved by the FDA or other county-specific regulators for the treatment of specific diseases after comprehensive research and clinical development to ensure its efficacy and safety in patients when administered at the recommended dose. Sales growth of marketed pharmaceutical products depends on multiple parameters, such as […]
Rx to OTC Switch: Overview, Regulatory Requirement and Potential Switch Candidates
Rx-to-OTC switch is the transfer of prescription-based drugs to non-prescription or over-the-counter status. It is a highly regulated and rigorous process that allows consumers to have OTC access to certain medicines with a high safety margin and is effective in treating self-diagnosable conditions. Over-the-counter products are broadly classified into key categories based on their therapeutic […]
Hunter Syndrome: Epidemiology, Treatment and Clinical Pipeline
Pathophysiology and Symptoms of Hunter Syndrome Hunter syndrome is a very rare genetic disorder in which a child’s body is not able to properly break down (digest) certain sugar molecules. When these sugar molecules accumulate in organs and tissues over a period of time, they can cause damage that affects the physical and mental development […]
Next-Generation Radiopharmaceuticals
Overview Next-generation radiopharmaceuticals are transforming disease diagnosis and treatment by combining radioactive isotopes with advanced targeting technologies. These agents are designed to identify specific biological markers, improve imaging accuracy, and deliver radiation more selectively to diseased cells, aiming to reduce damage to surrounding healthy tissues. A major development is theranostics, which integrates diagnostic imaging and […]
An In-Depth Look at Graft Versus Host Disease (GVHD)
Over the last five years, progress in GVHD understanding has redefined the GVH reaction and created new possibilities for novel preventive and therapeutic treatment innovations. The advancement in the immunology field has widened the new possibilities for hematopoietic stem cell transplant. This has led to the availability of different stem cell sources for possible grafts […]
Foam-Based Drug Delivery: Emerging Pharmaceuticals Dosage
The use of foam-based delivery systems in the field of drug delivery is an innovative approach in the sector of pharmaceutical science that has brought a new dispensation of drugs through creative formulations. Foam-based systems do not use typical dosage forms; instead, they change liquid drugs into stable foams as soon as they are activated […]
mRNA-Based Gene Editing Therapeutics
Genome editing has been gaining importance since the last decade as a potential alternative to gene therapy. Nucleases (ZFNs, TALENs, etc.) and the CRISPR–Cas9 system provide powerful tools for site-specific modification of genomes. However, these approaches have the risk of nonspecific editing as the DNA-based vectors translate the enzymes involved. In-vitro transcribed mRNA (IVT mRNA) […]